TWI360422B - - Google Patents

Download PDF

Info

Publication number
TWI360422B
TWI360422B TW95126182A TW95126182A TWI360422B TW I360422 B TWI360422 B TW I360422B TW 95126182 A TW95126182 A TW 95126182A TW 95126182 A TW95126182 A TW 95126182A TW I360422 B TWI360422 B TW I360422B
Authority
TW
Taiwan
Prior art keywords
lactic acid
health care
fermentation broth
care composition
hours
Prior art date
Application number
TW95126182A
Other languages
Chinese (zh)
Other versions
TW200806303A (en
Original Assignee
Tensall Bio Tech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tensall Bio Tech Co Ltd filed Critical Tensall Bio Tech Co Ltd
Priority to TW95126182A priority Critical patent/TW200806303A/en
Publication of TW200806303A publication Critical patent/TW200806303A/en
Application granted granted Critical
Publication of TWI360422B publication Critical patent/TWI360422B/zh

Links

Description

丄 JULKfZZ 九、發明說明: 【發明所屬之技術領域】 本剌侧於-種_於女赌料組合物 :於一種包含—乳_發酵液之應用於女性陰部的組ί 【先前技術】 的情況下,女性的陰道會分泌少許的分泌物, 该刀泌物具有潤滑陰道的作用,其對於陰道係不可或缺 的。但在衛生不佳或抵抗力下降的情形,有時會發生险道 分泌物增多,顏色改變且具有異味的現象,即係罹表了陰 ,炎。不正常的分泌物會造成患者患部極度搔療或: 痛,因而導致患者心理與生理上極大的不適。而陰道炎所 產生的分_尚可能造斜陰紅黯相的現象即係所 明的外陰炎,陰道炎及外陰炎可通稱為陰部錢。一般會 造成女性陰部感染的原因包括: 一、黴菌感染 黴菌感染中最常見的係白色念珠菌感染,白色念珠菌 容易在溫唆潮濕的環境下生長,在個人抵抗力不足時,容 易反覆發生感染(如睡眠不足、感冒、月經前後及懷孕期 間):其感染後的症狀包括搔癢、灼熱、外陰部紅腰、乳酿 塊狀的白色77'必物、尿道口酸痛紅腫、小便疼痛等,特別 係月經前後會特別不舒服。 5 1360422 二、細菌感染 細菌感染常見的症狀包括,性交後有大量灰白色或黃 色的分泌物,且細似歧味的臭味,大部分患者並沒有 搔癢的情形。過於頻繁的性交或太常沖洗陰道會導致陰道 pH值上升,此係細菌感染的主要原因,這是因為會造成感 染的細菌適合生存在偏鹼性的環境(pH > 4 5)。細菌感染最 常見的係混合型態的厭氧菌’造成細菌感染的細菌包括了 大陽桿菌(Escherichia⑶的、綠膿桿菌(Pseud〇m〇nas 齡吻《㈣)、金黃色葡萄球菌(伽着.)及鏈 球議亀{Streptococcus)專。 三、滴蟲感染 滴蟲感染的症狀為膿狀黃稍的分泌物,和細菌感染的 分泌物很類似,但滴蟲感染還會造成嚴重搔癢、性交後出 血、小便疼痛等現象,分泌物有時候會呈現綠色泡沫狀且 有臭味,通常在月經後症狀會更嚴重,内診時可看到子宮 頸的表皮有一點一點的紅點。滴蟲感染多半係經由性行為 傳染來的。 ^正常的陰道環境並不是無菌的,它包含了大約六種細 菌,當中有葡萄球菌、大腸桿菌、類白喉菌、念珠菌及乳 酸桿菌等菌。其中含量最多的乳酸桿菌係為益生菌,而葡 萄球菌、大腸桿菌、類白喉菌及念珠菌等係為壞菌,但「壞 菌」在量少的時候,對陰道的健康並不會產生不良的影響, 且只要陰道維持在正常菌相,也就是所謂的「益生菌」佔 優勢時,壞菌就不致大量滋生,因此就不會有前述感染的 6丄JULKfZZ IX. Description of the invention: [Technical field to which the invention pertains] The present invention is in the form of a composition for applying to the feminine genitals of a milk-containing fermentation liquid. Under the female vagina will secrete a small amount of secretions, the knife secretion has the role of lubricating the vagina, which is indispensable for the vaginal system. However, in the case of poor hygiene or decreased resistance, there are sometimes cases where the secretions of the dangerous passages increase, the color changes, and the smell is odorous, that is, the sputum shows yin and inflammation. Abnormal secretions can cause extreme paralysis or pain in the affected part of the patient, which can lead to psychological and physical discomfort. The vaginitis caused by the _ is still possible to create a phenomenon of oblique yin and red phlegm is the vulvitis, vaginitis and vulvitis can be known as genital money. The causes of female genital infections are generally as follows: 1. The most common fungal infection of fungal infections is Candida albicans. Candida albicans is easy to grow in a warm and humid environment. When individual resistance is insufficient, it is easy to reverse infection. (such as lack of sleep, cold, before and after menstruation and during pregnancy): The symptoms after infection include itching, burning, genital red waist, milky blocky white 77' must, urethral pain, redness, urinary pain, etc. It is particularly uncomfortable before and after menstruation. 5 1360422 II. Bacterial Infections Common symptoms of bacterial infection include a large amount of grayish-white or yellow secretions after sexual intercourse, and a odor-like odor. Most patients do not have itching. Too frequent sexual intercourse or too frequent flushing of the vagina can cause an increase in the pH of the vagina, which is the main cause of bacterial infections, because the bacteria that cause infection are suitable for survival in an alkaline environment (pH > 4 5). Bacterial infections are the most common mixed-type anaerobic bacteria' bacteria causing bacterial infections including Escherichia (Escherichia (3), Pseudomonas aeruginosa (Pseud〇m〇nas age kiss "(4)), Staphylococcus aureus (Galta) .) and the hammering ball {Streptococcus). Third, the symptoms of Trichomonas infection Trichomonas infection is a secretion of pus yellow, similar to the secretion of bacterial infection, but trichomoniasis infection can also cause severe itching, bleeding after sexual intercourse, urinary pain and other phenomena, secretions have It will appear green foamy and smelly. It usually gets worse after menstruation. You can see the redness of the cervix on the epidermis during internal diagnosis. Most of the trichomoniasis infections are transmitted through sexual behavior. ^The normal vaginal environment is not sterile. It contains about six kinds of bacteria, including Staphylococcus, Escherichia coli, Diphtheria, Candida and Lactobacillus. The most abundant Lactobacilli are probiotics, while Staphylococcus, Escherichia coli, Diphtheria-like and Candida are bad bacteria, but when the amount of "bad bacteria" is small, the health of the vagina will not be bad. The effect, and as long as the vagina is maintained in the normal fungus phase, that is, the so-called "probiotics" predominate, the bad bacteria will not breed a lot, so there will be no such infections.

If形發生。另外 即毁驗值約為pH 3 8 4 9 , 就是較偏祕性,如紐道的_ 偏巾4=也 性,則會有感染的情形發生。朝g一/成較偏中性或驗 維持在PH 3.8-4.2,而在此種^,道_驗值 陰道感染的病原體無法生長,造成 =而’當前錢道巾&_破壞時, 之感染狀況。現有治療女性陰部感染的方法,—般 =素併類固醇㈣品進行治療,但此往往會“ ,二併殺死:因而會造絲療初缝道環境呈現無= I,血生菌與壞菌互相競爭,但競爭 = 長往往勝於益生菌,因此容易發生重二:原兄體:: 反覆進仃、轉。但反覆使職生素及類固醇治療, 病原體產生抗’甚至會造成人體m統受損。 另外’現在市售的陰道保養品多為含硬的化學藥劑, 其在短期内雖然可減輕感染症狀’但由於其pH值為中性, 使用後會造成陰道pH值上升,轉變為適合病㈣生長的 環境,因此症狀容易復發,致使該症狀難以根治。因此, 積極尋找一種可用以抑制病原體生長,並同時能促進益生 菌生長,且不會刺激皮膚之新的防止陰道感染的組合物, 便成為一件極為重要的事。 【發明内容】 為解決前述習知技術的問題’本發明的目的即為提供 一種可維持陰道中正常菌相之應用於女性陰部的組合物。 本發明之另-目的㈣提供—種可使陰道酸驗值維持 在PH 3.8-4.2,以使病原體不易生長之應用於女性陰部的 組合物。 本發明之又一目的係提供一種不會產生抗藥性之應用 於女性陰部的組合物。 為達成本發明之目的,根據本發明所指出之一種應用 於女性陰部的組合物,其包含一乳酸菌發酵液,該乳酸菌 發酵液係藉由將一乳酸桿菌屬的菌株接種 於一奶類t,並在30〜45〇C下發酵培養而得。 上述乳酸桿菌屬的菌株可舉出的例子,包括了嗜酸性 乳酸桿菌(/^如办⑽·//⑽⑽)、比菲德氏菌 (Lactobacillus bifidus)、短乳酸桿蛰(Lactobacillus brevis)、 保加利亞乳酸桿菌Aw/gflr/cws)、乾酷·乳桿菌 (LactobaciUuS casei)、纖維二糖乳桿菌(LactobacilhdS cellobiosus)、}容膠乳样菌 QLactobdcilliis c〇Hin〇ides)、戴白 氏乳酸桿菌i/e/Arwech·/)、發酵乳桿菌 (Lactobacillus fennentum)、詹氏乳酸桿菌(Lactobacillus JmseW)、加氏乳酸桿菌肌、植物乳酸 得菌(Lactobacillus plantamm)、雷曼氏乳酸桿菌 (Lactobacillus rhamnosus)、激味二綠 Ί 得儀{Lactobacillus 、捲縮乳酸桿菌(ZflC/MflCZ·//⑽及德布 律克乳酸桿菌i/eArwech·/),較佳者係嗜酸性 乳酸桿菌C^cio6acz7/⑽πζ·ί/ο;?/ζζ7⑽)及乾酿乳桿菌 1360422 [Lactobacillus casef) 〇 上述乳酸桿菌屬的菌株可以單獨使用也可將不同種 或同種不同株之乳酸桿_的g株做任何結合。 類並無特別限制’可為各種動物所產的乳水, 也可為還原礼。動物所產的乳水之可舉出的例子包括 及年奶,較佳者為牛奶。The If shape occurs. In addition, the value of the damage is about pH 3 8 4 9 , which is more secretive. If the _ 偏 4 4 = yummy of the road, there will be infection. Towards g// is more neutral or maintained at pH 3.8-4.2, and in this case, the pathogen of vaginal infection cannot grow, resulting in = and the current money towel & _ destruction, Infection status. There are currently methods for treating female genital infections, such as steroids and steroids (four), but this tends to ", and kills: so the initial treatment of the silk treatment is no = I, blood bacteria and bad bacteria Competition, but competition = long is often better than probiotics, so it is easy to occur. The second brother: the original brother:: repeatedly into the sputum, turn. But repeatedly make the occupational and steroid treatment, the pathogen produces resistance, and even cause the human body In addition, 'the vaginal skin care products currently on the market are mostly hard chemical agents, which can alleviate the symptoms of infection in the short term'. However, because the pH value is neutral, the vaginal pH value will increase after use and become suitable. Disease (4) The environment in which the disease grows, so the symptoms are easy to relapse, making the symptoms difficult to cure. Therefore, actively looking for a new vaginal infection-preventing composition that can inhibit the growth of pathogens while promoting the growth of probiotics without irritating the skin. SUMMARY OF THE INVENTION In order to solve the problems of the prior art described above, the object of the present invention is to provide a condition for maintaining normality in the vagina. A composition for use in a female genital area. Another object of the present invention is to provide a composition for the female genital area which maintains the vaginal acid test value at pH 3.8-4.2 so that the pathogen is not easily grown. A further object is to provide a composition for application to a female genital area which does not produce drug resistance. For the purpose of the present invention, a composition for a female genital area according to the present invention, comprising a lactic acid bacterium fermentation broth, The lactic acid bacterium fermentation liquid is obtained by inoculating a strain of Lactobacillus in a milk t and fermenting it at 30 to 45 ° C. Examples of the strain of the genus Lactobacillus include eosinophilic lactic acid. Bacillus (/^如办(10)·//(10)(10)), Lactobacillus bifidus, Lactobacillus brevis, Lactobacillus bulgaricus Aw/gflr/cws, Lactobacillus UuS casei ), Lactobacilhd S cellobiosus, QLactobdcilliis c〇Hin〇ides, Lactobacillus licheniformis i/e/Arwech·/, Lactobacillus fermentum (Lactobacillu) s fennentum), Lactobacillus JmseW, Lactobacillus gamma muscle, Lactobacillus plantamm, Lactobacillus rhamnosus, scented green scorpion {Lactobacillus, crimped Lactobacillus (ZflC/MflCZ·//(10) and Labradorella breve i/eArwech·/), preferably Lactobacillus acidophilus C^cio6acz7/(10)πζ·ί/ο;?/ζζ7(10)) and dried milk Bacillus strain 1360422 [Lactobacillus casef) The above strains of the genus Lactobacillus may be used alone or in combination with the strains of lactic acid rods of different species or different strains. There is no special restriction on the class. It can be used for the milk produced by various animals. It can also be a reduction gift. Examples of the milk produced by the animal include annual milk, preferably milk.

習知技藝者均可輕易了解,上述發酵培養所需的時 ,,係依讀桿H屬㈣株之接種量及發酵培養溫度而 疋依上述之發酵培養溫度,較佳之發酵培養時間係為 12〜72小時’更佳為12〜36小時。 ;上述礼酸菌發酵液可進一步以去除菌體的步驟處理, 該去除菌體的步驟並無制限制,可舉出關子包括了離 心及過遽。 本發明之組合物可用以促進陰道内益生菌的生長,因It can be easily understood by the skilled artisan that when the above fermentation culture is required, the fermentation culture temperature is determined according to the inoculum amount of the H branch (four) strain and the fermentation culture temperature, and the preferred fermentation culture time is 12 ~72 hours 'better for 12 to 36 hours. The above-mentioned fermentation bacterium fermentation broth can be further treated by the step of removing the bacteria, and the step of removing the bacteria is not limited, and the separation includes centrifugation and sputum. The composition of the present invention can be used to promote the growth of probiotic bacteria in the vagina

此可使陰道中的pH值維持在正常的範圍内(pH 3.8-4.2), 由於習知病原體在此PH值下不易生長。因此本發明組合 物可^以抑制病原體(即’會造成陰道感染的微生物)的生 長藉以使陰道中的菌相維持在正常的狀態,故可用於預 防及治療女性陰部感染。 上述病原體可為任何會造成陰道感染的微生物,可舉 出的例子包括滴蟲、黴g及細菌,其中細菌主要為大腸桿 函( ‘chia c〇li)、綠藏得菌(pseud〇爪〇於似 ae”Uginosa)、 金拷色葡萄球菌(汾印知⑽)及鏈球菌屬 9 1360422 (Streptococcus)。 除具有上述特性外,本發明之組合物還具有溫和不刺 激,長時間使用亦不會造成皮膚過敏或刺激的優點,因此 可用於女性陰部平日及經财後的清潔與料。另外 發明之組合物可迅速降低陰道的PH #,避免女性在性 為後陰道pH值上升,因此可用於女性性行為後陰道^ 潔0This maintains the pH in the vagina within the normal range (pH 3.8-4.2), since conventional pathogens are not susceptible to growth at this pH. Therefore, the composition of the present invention can prevent the pathogenicity of a pathogen (i.e., a microorganism causing vaginal infection) to maintain the bacteriological phase in the vagina in a normal state, and thus can be used for preventing and treating female genital infection. The above pathogen may be any microorganism which causes vaginal infection, and examples thereof include trichomoniasis, mold g and bacteria, wherein the bacteria are mainly a large intestine function ('chia c〇li), a green bacterium (pseud 〇) It is similar to ae "Uginosa", Staphylococcus aureus (汾印知(10)) and Streptococcus 9 1360422 (Streptococcus). In addition to the above characteristics, the composition of the present invention is mild and non-irritating, and is not used for a long time. It can cause skin irritation or irritation, so it can be used for the cleaning and dressing of female genitals on a regular basis and after the financial period. In addition, the invented composition can quickly reduce the PH# of the vagina, avoiding the increase in the pH of the vagina after sex, so it is available After female sexual behavior, vagina ^ clean 0

為便於本發㈣合物之_,本發合物可依需要 被製成各種適合的劑型,在此可舉出的例子包括了喷劑、 凝露、凝修、乳液、霜、膏、塞劑、粉末、紙巾及棉棒, 但不僅限於此。In order to facilitate the present invention, the present invention can be prepared into various suitable dosage forms as needed, and examples thereof include sprays, gels, gels, lotions, creams, creams, and stoppers. Agents, powders, paper towels and cotton swabs, but are not limited to this.

本發明將藉由下述的實施方式做進一步的說明,下列 之實施例細關明本發明,並非用以限定本發明之範 圍。熟習本發明之技藝者,在不脫離本發明之精神和範圍 内,當可做些許之改良與修飾,因此本發明之保護範圍當 視後附之_請專利範圍所界定者為準。 【實施方式】 實施例1 乳酸菌發酵液之繁, 自食品工業發展研究所購得嗜酸性乳酸桿菌 (Lactobacillus acidophi㈣及乾輅乳椁菌(Lact〇bacUlus ,編號分別為BCRC 14079及BCRC 10697。將該兩 株礼I菌同時接種於新鮮牛奶中。此二株菌係從健康婦女 之生理泌尿系統中所篩選出之天然乳酸菌。接著在听 下培養24小時,藉以得到一乳酸菌發酵液。將該乳酸菌發 酵液離〜’使其固液分離,取其上清液並再以據 膜過濾,藉以除去發酵液中所含有之不溶 製程均在U),000級無塵室進行。 實施例2The invention is further illustrated by the following examples, which are not intended to limit the scope of the invention. It will be apparent to those skilled in the art that the present invention may be modified and modified without departing from the spirit and scope of the invention, and the scope of the present invention is defined by the scope of the appended claims. [Embodiment] Example 1 Lactic acid bacteria fermentation broth, Lactobacillus acidophi (4) and Lactobacillus faecalis (Lact〇bacUlus, numbered BCRC 14079 and BCRC 10697, respectively) were purchased from the Food Industry Development Institute. Two strains of I strain were simultaneously inoculated into fresh milk. The two strains were selected from natural lactic acid bacteria in the physiological urinary system of healthy women, and then cultured for 24 hours to obtain a lactic acid bacteria fermentation broth. The fermentation broth is separated from the ~' solid solution, and the supernatant is taken and filtered by the membrane to remove the insoluble process contained in the fermentation broth in a clean room of U), 000 class.

本實施例使用四種菌株,分別為大腸桿菌 <^)、綠膿桿菌(户從肌y、金黃色葡萄球 菌⑼印知/卿聲⑽)及鏈球菌屬⑼哪加·讓广該四 種菌株均為取自由中山醫學大學醫學中心分離自臨床檢 體,並經該醫學中心檢驗科細菌室經標準操作程序確認的 菌株。 將前述四種細菌分別接種至5 mL的Luria-Bertani培 養基中,並在37。(:下以200 rpm振盪培養。 經培養16小時後,將0.5 mL培養後的菌液分別加入 含有 1 mL、0.8 mL、0.6 mL、0.4 mL、0.2 mL 及 0 mL 本 發明乳酸菌發酵液的5.5mLLuria-Bertani培養基中,並在 37 C下以200 rpm振盪培養4.5小時。再以設定在6〇〇 nm 的分光儀測定菌液濃度(〇D600值)。 以含有0 mL本發明乳酸菌發酵液的菌液濃度當作 100%生長,分別算出 及 0.2 H1L 乳酸菌發酵=、0.8 mL、0.6 mL、0.4 mL 發明乳酸_液是否有之抑=株::: 發物在下痛的存^ 白+ ’可見到上述乳酸菌發酵液對四種細菌均有 二W)。/女制效曲果’其中該乳酸菌發酵液對葡萄球菌的 50。Pi辰度)約為15%,對大腸桿菌及綠膿桿菌的 實施例3 ;lLil讀發酵液斜夭社鼠的皮膚過斂詖齡 本實施例係採用Buehler試驗,亦即先給予試驗動物 誘導劑量的藥劑,經過誘導期後免疫反應產生,這時再給 予激發劑量的藥劑,以觀察是否出現過敏反應,此時係為 攻擊期。 本實施例中,皮膚的反應分為無反應(no reaction): 0, 輕微紅腫(slight erythema) : 1,中度紅腫(moderate erythema) : 2,強度紅腫及水腫(severe erythema and edema) : 3。 實驗開始時將天竺鼠分為對照組(逆滲透去離子水)、 陽性對照組(2, 4-二硝基·4•氯苯(2, 12 :8) 1360422 4-dinitnM-Chl〇robenzene,DNCB))及乳酸菌發酵液組 明乳酸菌發酵液),陽性對照組在誘導期及攻擊期根i Shirasu與Matsuoka之測試濃度,分別使用〇 5 mL 。乳酸菌發酵液 的未稀釋乳酸菌In this example, four strains were used, namely Escherichia coli <^), Pseudomonas aeruginosa (housefly muscle y, Staphylococcus aureus (9) Ink/Qingsheng (10)) and Streptococcus (9) The strains were all taken from the clinical center of the Medical Center of Zhongshan Medical University and confirmed by the standard operating procedures of the bacteria room of the laboratory of the medical center. The aforementioned four bacteria were inoculated separately into 5 mL of Luria-Bertani medium and at 37. (: The culture was shaken at 200 rpm. After 16 hours of culture, the 0.5 mL cultured bacterial solution was added to the fermentation broth containing 1 mL, 0.8 mL, 0.6 mL, 0.4 mL, 0.2 mL, and 0 mL of the lactic acid bacteria of the present invention. In mL Luria-Bertani medium, incubate at 200 C for 4.5 hours at 37 ° C. The concentration of the bacteria solution (〇D600 value) was measured with a spectrometer set at 6 〇〇 nm. The fermentation broth containing 0 mL of the lactic acid bacteria of the present invention was used. The concentration of the bacterial liquid was taken as 100% growth, and the fermentation of 0.2 H1L lactic acid bacteria was calculated, 0.8 mL, 0.6 mL, and 0.4 mL. Invented lactic acid _ liquid is not inhibited = strain::: The hair in the lower pain is stored white + 'visible To the above lactic acid bacteria fermentation broth has two W for four bacteria. / Female effect curve 'The lactic acid bacteria fermentation broth is 50 for Staphylococcus. Pi Chen degree) is about 15%, Example 3 for Escherichia coli and Pseudomonas aeruginosa; lLil reading fermentation broth 夭 夭 夭 的 皮肤 皮肤 皮肤 皮肤 本 本 本 本 本 本 本 本 本 本 本 本 本 本 本 本 本 本 本 本 本 本 本 本 本The dose of the agent is produced after the induction period, and then an active dose of the agent is administered to observe whether an allergic reaction occurs, and this is an attack period. In this example, the skin reaction is divided into no reaction: 0, slight erythema: 1, moderate erythema: 2, intensity redness and edema (severe erythema and edema): 3 . At the beginning of the experiment, the guinea pigs were divided into the control group (reverse osmosis deionized water) and the positive control group (2, 4-dinitro- 4 chlorobenzene (2, 12:8) 1360422 4-dinitnM-Chl〇robenzene, DNCB )) and the lactic acid bacteria fermentation broth group lactic acid bacteria fermentation broth), the positive control group in the induction period and the attack period root i Shirasu and Matsuoka test concentration, respectively, using mL 5 mL. Undiluted lactic acid bacteria in lactic acid bacteria fermentation broth

l%(w/v)DNCB 及 0.5 mL 〇.1%(w/v)dnCB 組在誘導期及攻擊期則均係採用〇 5 mL 發酵液。 本實施例中對照組包括10隻天竺鼠,其中五隻為雄 鼠,五隻為雌鼠;陽性對照組包括1〇隻天竺鼠其中五隻 為雄鼠,五隻為雌鼠;乳酸菌發酵液組包括2〇隻天竺鼠, 其中十隻為雄鼠,+隻為_鼠。前三週分別將三組的天竺 鼠右腰窩部4x6 Cm區域的毛剃除乾淨,將〇 5 mL逆滲透 去離子水、0.5 mL之1%DNCB及0.5 mL本發明乳酸菌發 酵液分別塗佈在一平方英忖的四層紗布上,並分別貼於各 組天竺鼠右腰部剃毛區域’再以透氣膠布(Micr〇p〇reTM,3M, 81,]\^,1;8八)及黏著彈性繃帶(£;1^7^,八1(^,1^0, Japan)包紮六小時’六小時後取下紗布,以逆滲透去離子 水沖淨藥劑,在取下紗布後24及48小時觀察並記錄該剃 毛區域紅腫的情形。 第四週天竺鼠不以藥劑處理。第五週於試驗前一天將 前述各組天竺鼠左腰窩部的毛剃除乾淨,取〇 5mL 10%之 十二基硫酸鈉(sodium dodecyl sulfate,SDS)(w/v)(大阪和光 純藥株氏會社)塗抹於剃毛區域以加強辨識皮膚刺激及過 敏現象,六小時後以逆滲透去離子水沖淨藥劑,隔天取0.5 mL逆滲透去離子水、〇 5 mL之〇.i〇/0 DNCB及0.5 mL本 1360422 發酵液分別塗佈在-平方英吋的四層紗布上’ 强卜4 I各組天竺鼠左腰部剩毛區域,再以透氣膠布及 包紫二十四小時,二十四小時後取下紗布, ㈣L離子水冲乎藥劑,取下紗布後24、48及72小 ,=並記錄該剃毛區域紅腫的情形。第—週至第六週所 付結果不於表二至表四。 έ 經及猶菌發酵液組在第一週至第三週均無皮膚 ’而參閱表二至表四,可知陽性對照組的天竺鼠 二一週右腰窩部皮膚即出現中等程度紅腫症狀,第二及 -週則出現中度至強度紅腫症狀,並有明祕皮產生。 „酸菌發酵液組在第五及第六週均無皮膚紅腫反 U膚過敏陽性率均為0%。而陽性對照組的天竺鼠在 2及第六测出現嫌至巾度紅難狀,錢過敏陽性 。1〇〇/0 ’等級屬於ν,為「極度過敏性藥物」。對昭組 及乳酸菌發酵液組皮膚過敏陽性率均為Q%,等級屬於、!、, 為「無過敏性」。因此,由此可得知本發明乳酸菌發酵液益 皮膚過敏性(non dermal sensitization)。 另外’於第-至六週分別測量天竺鼠的體重並加以記 錄,結果請參閱表五及表六。觀察的結果,發現陽性對昭 組的雄鼠在第五週時,雌鼠在第六料,體重和對昭扯 較有明顯的下降趨勢(P&lt;0.05),其係以鄧肯多重差距檢定 (duncan multiple range test)測得’而乳酸菌發酵液組的^ ^ 和對照組比較則無明顯差異,可知該乳酸菌發酵液不合 身體造成不良的影響。 θ于 14 1360422 實施例4 酵液斜白条的成膚過敏試驗 本實施例包括6隻白兔,選取其背部皮膚正常區域, 於試驗前一天以電動剃毛剪將白兔背部約4x6 cm面積的 毛剃除’剃毛時不可傷及皮膚。接著取0.5 mL經粉碎之乳 酸菌發酵液,置於以蒸餾水潤濕的一平方英吋之四層紗布 上’將紗布貼在白兔背部的剃毛區域,再以透氣膠布 (MicroporeTM,3M, St,MN,USA)及黏著彈性繃帶(ELATEX, Alcare,Tokyo, Japan)包紮四小時,四小時後取下紗布,以 足量的水沖淨藥劑,並在第4、24、48及72小時觀察並記 錄皮膚的刺激性,若皮膚刺激性未消失,則需再持續觀察 4、7及14天。依Draize法之判定標準加以分析,將刺激 指數(紅腫/結痂及水腫)相加後,再求出個別白兔皮膚刺激 指數(Primary,irritation index)。所得平均指數值為乳酸菌發 酵液對白兔之皮膚刺激指數等級。結果示於表七。 從表七中可得知,以乳酸菌發酵液處理的皮膚區域, 在除去紗布後均無明顯紅腫情形。依據以如皮膚刺激指 數評估法’該乳酸菌發酵液在第4、24、48及72小時的红 腫、結旅及水狀平均触指數均為G。依據加^試驗 之皮膚刺激指數評估法,該乳㈣發酵液對白兔皮膚刺激 性等級屬於無皮膚刺激性。 v 15 1360422 表一不同含量乳酸菌發酵液存在下各菌株的存活率(%) 乳酸菌發酵 液(mL) 大腸桿菌 綠膿桿菌 葡萄球菌 鏈球菌 1.0 21.0 32.4 47.1 5.4 0.8 36.9 51.6 57.9 16.7 0.6 71.0 57.1 75.4 49.7 0.4 88.0 93.6 88.9 73.7 0.2 100.0 94.2 94.5 100.0 0.0 100.0 100.0 100.0 100.0The l% (w/v) DNCB and 0.5 mL 〇.1% (w/v) dnCB groups were treated with 〇 5 mL fermentation broth during the induction and challenge phases. In the present example, the control group includes 10 guinea pigs, five of which are male and five are female; the positive control group includes one guinea pig, five of which are male and five are female; the lactic acid fermentation broth includes 2 竺 竺 ,, 10 of which are male, + only _ mouse. In the first three weeks, the hairs of the 4x6 Cm region of the right scorpion of the three groups of guinea pigs were shaved, and 5 mL of reverse osmosis deionized water, 0.5 mL of 1% DNCB, and 0.5 mL of the lactic acid bacteria fermentation broth of the present invention were separately coated. One square inch of four layers of gauze, respectively, attached to each group of guinea pigs in the right waist shaving area 'and then breathable tape (Micr〇p〇reTM, 3M, 81,] \ ^, 1; 8 eight) and adhesive elasticity Bandage (£; 1^7^, 8 1 (^, 1^0, Japan) for six hours' after six hours, remove the gauze, reverse the osmotic deionized water, and remove the gauze 24 and 48 hours after removing the gauze. The redness of the shaved area was observed and recorded. The fourth day of the day, the mole was not treated with the drug. On the fifth week, the hair of the left flank of each group of guinea pigs was shaved off one day before the test, and 5 mL of 10% was taken. Sodium sulfate (SDS) (w/v) (Osaka and Koko Pure Chemical Industries, Ltd.) was applied to the shaved area to enhance skin irritation and allergies. After six hours, the reverse osmosis deionized water was used to clean the remedy. Take 0.5 mL of reverse osmosis deionized water, 〇 5 mL of 〇.i〇/0 DNCB and 0.5 mL of this 1360422 fermentation every other day. They were coated on the four-layer gauze of - square inch respectively. 'The strong left hair area of the scorpion scorpion of each group, and then the breathable tape and the bag purple for twenty-four hours. After 24 hours, remove the gauze. (4) L ion The water is flushed with the medicine, 24, 48 and 72 after the gauze is removed, and the redness of the shaved area is recorded. The results from the first week to the sixth week are not shown in Tables 2 to 4. The liquid group had no skin from the first week to the third week. Referring to Tables 2 to 4, it can be seen that the guinea pigs in the positive control group showed moderate redness in the right lower lumbar skin for two weeks, and the second and the week appeared. Symptoms of moderate to intense redness and swelling, and secretory skin production. „The acid bacteria fermentation liquid group had no skin redness and anti-U skin allergy positive rate in the fifth and sixth weeks, and the positive control group’s guinea pig was in 2 The sixth test showed that the redness of the towel was too difficult, and the money was allergic. The 1〇〇/0 'grade belongs to ν, which is “extremely allergic drug.” The positive rate of skin allergy to Zhao group and lactic acid bacteria fermentation liquid group is Q%. , the grade belongs to, !,, is "no allergic". Therefore, it is available It is known that the lactic acid bacteria fermentation broth of the present invention is non-dermal sensitization. In addition, the body weight of guinea pigs is measured and recorded in the first to sixth weeks, and the results are shown in Tables 5 and 6. The results of the observations show that the positive sputum is positive. In the fifth week of the male rats in the group, the females showed a significant downward trend (P<0.05) in the sixth material, and the weight was measured by the Duncan multiple range test. However, there was no significant difference between the γ lactic acid fermentation broth group and the control group, and it was found that the lactic acid bacteria fermentation broth did not affect the body adversely. θ at 14 1360422 Example 4 Skin allergy test of the lyophilized white strip of the yeast solution This example includes 6 white rabbits, and the normal area of the back skin is selected, and the back of the white rabbit is about 4x6 cm area by electric shaving scissors one day before the test. Hair shaving can't hurt the skin when shaving. Next, take 0.5 mL of the pulverized lactic acid fermentation broth and place it on a square inch of gauze wetted with distilled water. Place the gauze on the shaved area on the back of the white rabbit, and then use a breathable tape (MicroporeTM, 3M, St , MN, USA) and adhesive elastic bandage (ELATEX, Alcare, Tokyo, Japan) were bandaged for four hours. After four hours, the gauze was removed and the drug was flushed with sufficient water and observed at 4, 24, 48 and 72 hours. Also record the irritation of the skin. If the skin irritation does not disappear, continue to observe for 4, 7 and 14 days. According to the criteria of the Draize method, the stimulation index (redness/crustosis and edema) was added, and then the individual white rabbit skin irritation index (Primary, irritation index) was obtained. The average index value obtained is the skin irritation index level of the lactic acid bacteria fermentation broth to white rabbits. The results are shown in Table 7. It can be seen from Table 7 that the skin area treated with the lactic acid bacteria fermentation broth has no obvious redness after removal of the gauze. According to the evaluation method such as skin irritation index, the average susceptibility index of redness, journey and water in the lactic acid bacteria fermentation broth at 4, 24, 48 and 72 hours was G. According to the skin irritation index evaluation method of the plus test, the milk (four) fermentation broth has no skin irritation to the skin irritation grade of the white rabbit. v 15 1360422 Table 1 Survival rate of each strain in the presence of different lactic acid bacteria fermentation broth (%) Lactic acid bacteria fermentation broth (mL) Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus 1.0 21.0 32.4 47.1 5.4 0.8 36.9 51.6 57.9 16.7 0.6 71.0 57.1 75.4 49.7 0.4 88.0 93.6 88.9 73.7 0.2 100.0 94.2 94.5 100.0 0.0 100.0 100.0 100.0 100.0

表二天竺鼠皮膚過敏試驗之誘導期中陽性對照組皮膚的 反應Table 2: Response of the skin of the positive control group during the induction period of the guinea skin allergy test

第一週 第二週 第三週 性別 編號 24小時 48小時 24小時 48小時 24小時 48小時 雄鼠 311 1 1 4 3 4 4 312 1 1 3 2 3 2 313 1 1 4 3 3 2 314 1 1 4 4 3 3 315 1 1 3 4 4 4 雌鼠 316 1 1 3 3 3 2 317 1 1 3 3 3 2 318 1 1 4 3 2 3 319 1 1 4 4 4 3 320 1 1 4 4 3 3 16 1360422 表三天竺鼠皮膚過敏試驗之攻擊期中陽性對照組皮膚的 反應 第五週 第六週 性別 編號 24小時 48小時 24小時 48小時 雄鼠 311 1 0 4 4 312 1 1 1 1 313 1 0 1 1 314 1 1 4 4 315 1 0 4 4 雌鼠 316 1 0 4 4 317 1 1 4 4 318 1 0 1 1 319 1 0 4 4 320 1 0 4 4First week second week third week gender number 24 hours 48 hours 24 hours 48 hours 24 hours 48 hours male rats 311 1 1 4 3 4 4 312 1 1 3 2 3 2 313 1 1 4 3 3 2 314 1 1 4 4 3 3 315 1 1 3 4 4 4 Female 316 1 1 3 3 3 2 317 1 1 3 3 3 2 318 1 1 4 3 2 3 319 1 1 4 4 4 3 320 1 1 4 4 3 3 16 1360422 Response of the skin of the positive control group during the attack period of the three-day squirrel skin allergy test. Week 5 Week 6 Gender number 24 hours 48 hours 24 hours 48 hours Male 311 1 0 4 4 312 1 1 1 1 313 1 0 1 1 314 1 1 4 4 315 1 0 4 4 Female 316 1 0 4 4 317 1 1 4 4 318 1 0 1 1 319 1 0 4 4 320 1 0 4 4

表四天竺鼠皮膚過敏試驗之等級及分類Table 4 The level and classification of the skin allergy test of the mole rat

所有試驗 動物 所有陽性 反應動物 敏感率(%) 等級 分類 對照組 10 0 0(0/10) I 無過敏性 陽性對照 組 10 10 100(10/10) V 極度過敏 性 乳酸菌發 酵液組 20 0 0(0/20) I 無過敏性 17 1360422Sensitivity of all positive animals in all test animals (%) Graded control group 100 (0/10) I No allergic positive control group 10 10 100 (10/10) V Extremely allergic lactic acid bacteria fermentation broth group 20 0 0 (0/20) I No allergies 17 1360422

表五天竺鼠皮膚過敏試驗中雄鼠的體重變化 第一週 第二週 第三週 第四週 第五週 第六週 對照組 平均值 327.0 354.8 403.4 474.5 497.4 517.1 標準差 7.1 9.6 15.5 20.2 19.0 32.8 陽性對照 平均值 329.2 378.4 401.6 458.9 365.1 417.5 組 標準差 23.3 19.7 20.7 20.6 34.4 24.0 乳酸菌發 平均值 349.4 365.9 381.0 438.3 467.7 503.3 酵液組 標準差 16.8 24.3 31.2 31.3 27.9 30.5 表六 天竺鼠皮膚過敏試驗中雄鼠的體重變化 第一週 第二週 第三週 第四週 第五週 第六週 對照組 平均值 324.2 351.8 393.4 421.9 440.8 487.7 標準差 14.6 33.6 29.1 34.6 37.6 43.7 陽性對照 平均值 322.4 . 344.2 371.6 396.0 441.0 425.6 組 標準差 13.0 13.6 20.3 34.8 27.3 35.8 乳酸菌發 平均值 332.0 345.4 368.2 427.1 464.8 酵液組 標準差 19.5 20.1 23.9 30.1 15.3The weight change of male rats in the skin sensitization test of the fifth day of the first week, the second week of the third week, the fourth week, the fourth week, the fifth week, the sixth week, the average value of the control group 327.0 354.8 403.4 474.5 497.4 517.1 standard deviation 7.1 9.6 15.5 20.2 19.0 32.8 positive control Mean 329.2 378.4 401.6 458.9 365.1 417.5 Group standard deviation 23.3 19.7 20.7 20.6 34.4 24.0 Average value of lactic acid bacteria 349.4 365.9 381.0 438.3 467.7 503.3 Standard deviation of the yeast solution group 16.8 24.3 31.2 31.3 27.9 30.5 Weight changes of male rats in the skin allergy test of the six-day squirrel First week, second week, third week, fourth week, fifth week, sixth week, sixth week, control group average 324.2 351.8 393.4 421.9 440.8 487.7 standard deviation 14.6 33.6 29.1 34.6 37.6 43.7 positive control average 322.4 . 344.2 371.6 396.0 441.0 425.6 standard deviation 13.0 13.6 20.3 34.8 27.3 35.8 Average value of lactic acid bacteria 332.0 345.4 368.2 427.1 464.8 Standard deviation of yeast solution group 19.5 20.1 23.9 30.1 15.3

18 表七白兔皮膚過敏試驗之皮膚刺激指數 4小時 24小時 48小時 72小時 紅腫/結旅 0.0 0.0 0.0 0.0 水腫 0.0 0.0 0.0 0.0 平均指數 0.0 0.0 0.0 0.0 1360422 【圖式簡單說明】 無 【主要元件符號說明】 無 1918 Table 7 Skin irritation index of white rabbit skin allergy test 4 hours 24 hours 48 hours 72 hours redness / knot 0.0 0.0 0.0 0.0 Edema 0.0 0.0 0.0 0.0 Average index 0.0 0.0 0.0 0.0 1360422 [Simple diagram] No [main components Explanation of symbols] No 19

Claims (1)

13604221360422 丨.-鶴用於獅及/或治療女性陰部㈣的醫藥保健組合 物,其包含-乳酸菌發酵液,該乳酸菌發酵液係藉由將一 $酸性碰桿菌(LaetGbaeillus aeidGphiIus)及—乾酪乳酸 桿菌(Lactebacmus casei)菌株接種於一奶類中,在3〇〜机 鲁 下發酵培養後並去除菌體而得,該乳酸菌發酵液無皮膚過 敏性(non dermal sensitizatiGn) ’並可促進陰道内益生菌之 生長。 2. 如申請專纖圍第丨項所述之⑽保健組合物,其中該乳 醆菌發酵液係在30〜45。(:下經發酵培養12〜72小時而得。 3. 如申請翻細第2斯述之賤健組合物,其中該乳 酸菌發酵液係在30〜451下經發酵培養12〜36小時而得。 # 4.如申請專利範圍第1項所述之醫藥保健組合物,其中該去 除菌體的步驟係離心。 5. 如申請專利範圍第1項所述之醫藥保健組合物,其中該去 _ 除菌體的步驟係過濾。 6. 如申請專利範圍第1項所述之醫難健組合物,其中女性 陰部感染係病原體所導致。 7. 如申請專利範圍第6項所述之醫藥保健組合物,其中該病 20 1360422 . ' 原體係選自滴蟲、黴菌與細菌所組成之群組。 8. 如申請專利範圍第7項所述之醫藥保健組合物’其中該細 菌係選自大腸桿菌(Escherichia coli)、綠膿桿菌 (Pseudomonas aeruginosa)、金黃色葡萄球菌 (Staphylococcus aureus)及鍵球菌屬(Streptococcus)所組成 之群組。 9. 如申請專利範圍第1項所述之醫藥保健組合物,其中該組 合物的劑型係選自噴劑、凝露、凝膠、乳液、霜、膏、塞 劑、粉末、紙巾及棉棒所組成的群組。丨.- Crane for lion and / or treatment of female genitals (four) of the medical and health care composition, comprising - lactic acid bacteria fermentation broth by lactic acid bacteria by LacGbaeillus aeid GphiIus and Lactobacillus - The Lactebacmus casei) strain is inoculated into a milk, and is obtained by fermentation and removal of the cells under 3〇~机鲁, the lactic acid bacteria fermentation broth is non-dermal sensitizatiGn' and can promote probiotics in the vagina. Growing. 2. For the (10) health care composition as described in the special item, the lactobacillus fermentation broth is between 30 and 45. (: The fermentation is carried out for 12 to 72 hours. 3. For the application of the second embodiment of the medicinal composition, the lactic acid fermentation broth is fermented for 12 to 36 hours at 30 to 451. The medical and health care composition according to claim 1, wherein the step of removing the cells is performed by centrifugation. 5. The medical and health care composition according to claim 1, wherein the removal is The step of the cell is filtered. 6. The medical refractory composition according to claim 1, wherein the female genital infection is caused by a pathogen. 7. The medical and health care composition according to claim 6 Wherein the disease is 20 1360422. The original system is selected from the group consisting of trichomoniasis, mold and bacteria. 8. The pharmaceutical health care composition according to claim 7 wherein the bacterium is selected from the group consisting of Escherichia coli ( Escherichia coli), a group consisting of Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus 9. The pharmaceutical health care composition of claim 1 Wherein the composition is a dosage form selected from the group spray, condensation, gel, lotion, cream, ointment, suppository, powder, paper towels and swabs thereof. 21twenty one
TW95126182A 2006-07-18 2006-07-18 Composition applied to female pudendum TW200806303A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW95126182A TW200806303A (en) 2006-07-18 2006-07-18 Composition applied to female pudendum

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW95126182A TW200806303A (en) 2006-07-18 2006-07-18 Composition applied to female pudendum

Publications (2)

Publication Number Publication Date
TW200806303A TW200806303A (en) 2008-02-01
TWI360422B true TWI360422B (en) 2012-03-21

Family

ID=44766295

Family Applications (1)

Application Number Title Priority Date Filing Date
TW95126182A TW200806303A (en) 2006-07-18 2006-07-18 Composition applied to female pudendum

Country Status (1)

Country Link
TW (1) TW200806303A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI754126B (en) * 2018-07-19 2022-02-01 大江生醫股份有限公司 Use of probiotic composition for improving microflora of female vagina and external hygiene products

Also Published As

Publication number Publication date
TW200806303A (en) 2008-02-01

Similar Documents

Publication Publication Date Title
CN105189732B (en) Prevent and/or treat the method with the relevant infection of pathogenic bacteria, field planting or disease
JP4678896B2 (en) Topical use of symbiotic Bacillus spores to prevent or control microbial infection
JP2003507428A (en) Improved topical compositions comprising commensal bacteria, spores and extracellular products, and uses thereof
CN101175503A (en) Composition and method for regulating and remaining vaginal flora and vaginal acidity be normal
JP2003507437A (en) Use of emu oil, a carrier for antifungal, antibacterial, and antiviral drugs
CN105663172A (en) Ecological gynaecological externally-applied medicine composition and preparation method and application thereof
US20240050488A1 (en) Ammonia oxidizing microorganisms for the treatment of diaper rash, athlete’s foot, contact dermatitis, perspiration, and body odor
CN113278548B (en) Lactobacillus crispatus and application thereof in producing products for improving human vaginal environment
US20230128070A1 (en) Ammonia oxidizing microorganisms for use and delivery to the urogenital system
CN101797269B (en) Physiological balance liquid for adjusting microecology in vaginas of women
CN101543514A (en) Compound lactobacillus vagina cleaning hygiene body lotion for preventing or treating vaginitis and technology thereof
CN113274414A (en) Probiotics preparation for repairing and maintaining vaginal microecological balance
TWI360422B (en)
von Laer Tschudin et al. Tinea capitis: no incision nor excision
TW202218677A (en) External composition for wound healing containing lactobaccilus fermentation product and use thereof
TWI731209B (en) Probiotics composition and uses thereof
CN106047767A (en) Microbial bacteria powder additive for sanitary napkins and health pads, and preparation method of microbial bacteria powder additive
TW201316996A (en) A novel strain of Lactobacillus and its use in inhibition of vaginitis
CN100584376C (en) Medicine for treating deep erosive trauma with crust
AU2006201179B2 (en) Use of Emu Oil Carrier for Antifungal, Antibacterial, and Antiviral Medications
CN104511046A (en) Women&#39;s menstrual antibacterial nursing pad prepared from water lily extract
CN114891692B (en) Strain for improving human vagina environment and application thereof
TW201121580A (en) Vaginal cleaner and manufacture method thereof
CN109432204B (en) Silver ion spray and preparation method thereof
US20230414678A1 (en) Shelf- stable ammonia oxidizing microorganism preparations